NSE: CLOSED BSE: CLOSED MCX: CLOSED | 🕐 IST 5:22 AM |
NIFTY 50 23,140.50 -1.31% SENSEX 73,895.74 -1.25% INDIA VIX 12.16 +17.49% GIFT NIFTY 23,188.50 +0.39%
IST · automated real-time feeds
Market Analysis 23.09.2026

IPO Multibagger Meltdown: Why 10 Top Debutants are Now Trading Below Listing Highs

Analysis of 10 IPO multibaggers reveals a 100% failure rate in sustaining listing-day peaks — valuation audits and risk factors for momentum investors.

MUMBAI / NEW DELHI, SEPTEMBER 23, 2026 — During trading on Wednesday, September 23, 2026, a stark reality check hit primary market investors as data revealed that all 10 IPO multibaggers of the last two years have significantly retraced from their listing-day peaks. Despite stellar debuts, stocks like Vibhor Steel Tubes and Mamata Machinery are grappling with selling pressure as the gap between listing euphoria and fundamental valuation narrows, leaving late-entrants in the red.

Editorial Integrity & Fact-Verification: Cross-verified against primary regulatory filings (BSE, NSE, SEBI), statutory offer documents (RHP/DRHP), and market tracking platforms (Chittorgarh, IPOWatch, Screener). Reviewed by Raj Verma, IPO Bulletin Editorial Desk.

Key Performance Timeline & Market Milestones

Event / Catalyst Milestone Exact Calendar Date
Helios Capital Reality Check on IPOs August 24, 2026
Lumino Industries Listing Debut (+41.5%) September 04, 2026
ESDS Share Price Peak (+264%) September 10, 2026
FII Outflow Analysis (₹2.8 Lakh Cr Exit) September 11, 2026
Data Analysis: 10/10 Multibaggers Bleed September 23, 2026

Post-Listing Performance & Valuation Metrics

Metric Description Value / Percentage
ESDS 5-Day Listing Gain 264.00%
Lumino Industries Listing Premium 41.50%
FII Secondary Market Exit (Last 12 Months) ₹2,80,000 Cr
Multibaggers Below Listing Highs 10 / 10
Average Retracement from Peak Pending Audit

In-Depth Analysis: The Perils of Chasing Listing Day Highs

According to market intelligence from The Economic Times and Moneycontrol, the recent trend of “IPO chasing” has led to significant capital erosion for retail investors who enter stocks post-listing. While the primary market remains hot — with FIIs pumping ₹47,000 crore into new offerings despite pulling ₹2.8 lakh crore from listed stocks — the secondary market performance of these debutants tells a different story.

The “Samir Arora” Reality Check

On August 24, 2026, Samir Arora of Helios Capital provided a critical perspective, noting that many investors “made 1% on their money” after accounting for the massive oversubscription and limited allotment. Chasing these stocks on the listing day often means buying at the point of maximum optimism and peak valuation. Data from Screener.in highlights that many of these multibaggers, including Vibhor Steel Tubes, saw their P/E multiples expand to unsustainable levels within hours of trading.

FII Strategy: Primary vs. Secondary

Research compiled by Motilal Oswal suggests a structural shift. Foreign Institutional Investors (FIIs) are increasingly using IPOs as a localized entry point where they can secure bulk allocations at issue prices, only to see retail demand drive prices to irrational highs. Once the initial lock-in periods or momentum fades, these stocks often revert to mean valuations, as seen in the recent correction across all 10 top-performing IPOs of the last two years.

Peer Comparison: IPO High-Flyers vs. Industry Benchmarks

Company / Peer Name P/E Ratio (TTM) Market Cap (₹ Cr) Key Note
Vibhor Steel Tubes 48.2 ~850 Trading 35% below peak
APL Apollo Tubes (Peer) 55.1 42,500 Industry leader benchmark
Hi-Tech Pipes (Peer) 38.4 2,100 Mid-cap valuation anchor

Peer valuation data sourced from Screener.in and Trendlyne as of September 23, 2026.

Bull vs. Bear Framework

  • Growth Catalysts (Bull): Strong order books for companies like ESDS and Lumino Industries suggest long-term revenue visibility despite short-term stock price volatility.
  • Downside Risks (Bear): Extreme listing premiums (e.g., ESDS at 264%) create a “valuation trap” where earnings growth may take years to catch up with the stock price.

Investment Verdict

Suitable For: Long-term Institutional Investors only; Retail should exercise extreme caution.

Risk Level: High — 100% of analyzed multibaggers have failed to hold their listing-day highs.

Key Watch Point: Monitor the stabilization of P/E multiples relative to sector peers before considering post-listing entries.

Frequently Asked Questions

Should investors buy IPO shares at listing day highs?

Historical data from the last two years suggests that buying at listing day highs is a high-risk strategy, as 10 out of 10 top-performing IPOs are currently trading below those levels. Investors should wait for the “listing euphoria” to settle and for the stock to undergo price discovery over 3-6 months.

Why are multibagger IPOs falling despite strong debuts?

The primary reason is valuation mismatch; listing gains are often driven by liquidity and oversubscription rather than fundamental earnings. When initial momentum slows and early investors book profits, the lack of institutional support at inflated prices leads to a sharp retracement.

What are the primary risks for IPO investors in 2026?

The main risks include inflated entry costs, high FII volatility in the secondary market, and the “lottery effect” where small allotments provide negligible real returns despite high percentage gains, as noted by Helios Capital.

SEBI Compliance & Statutory Disclaimer

The information and analysis presented on IPO Bulletin (ipobulletin.com) are for informational and educational purposes only and do not constitute financial, investment, or legal advice. Securities market investments are subject to market risks; please read all offer documents (DRHP/RHP) thoroughly before committing capital. Grey Market Premium (GMP) figures are unofficial, unregulated street estimates. Always consult a SEBI-registered investment advisor before making financial decisions.

Sources cross-checked for this article: Economic Times, Moneycontrol, Livemint, BSE India filings, Screener.in, Motilal Oswal Research.